At a glance
- Originator Merck & Co
- Class Analgesics; Antipyretics; Nootropics
- Mechanism of Action Muscarinic M1 receptor agonists; Muscarinic M3 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 21 Jan 1997 No-Development-Reported for Alzheimer's disease in United Kingdom (Unknown route)